Short-TermMedium-TermLong-TermSignals

Nurix Therapeutics Inc [NRIX]

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Last Updated 12 Jun 2026 @ 16:00 (Exchange is closed for the weekend)
Last: $16.95 -0.18%
0.82 (↑)
GaG Algo Score™
v1.0
Short
0.82 (↑)
Medium
2.50 (↑)
Long
2.08
BUY
71.43%
return 44.31%
SELL
32.00%
return 46.81%

Stats

Today's Volume 2.56M
Average Volume 1.68M
Market Cap 1.47B
EPS $-0.790 (Q1 | 2026-04-08)
Next earnings date ($-0.730) 2026-07-09
P/E -5.35 (Sector) 26.21 (Industry) 17.28
ATR14 $1.537 (9.07%)
Possible DaySwing $16.18 - $17.72 (9.50%)

Support and Resistance Levels

Line

Pivot Data

Pivot Statistics
Metric Average Median Std Dev
Gain % 16.54% 16.54% 0.00%
Loss % -17.57% -17.57% 0.00%
Duration 8.5d 9d 2.1d
Total Pivots Found 3
Gain/Loss Legs 2 (1 Gain / 1 Loss)
Last Pivot Bottom @ $14.64 on 2026-06-05
Change since Last Pivot $2.31 (15.78%)
Next Pivot Prediction Last: $16.95
Predicted Next Type Top
Predicted Price (Avg) $17.06
Predicted Price (Median) $17.06
Predicted Price Range (~68%) $17.06 - $17.06
Change to Avg Target $0.11 (0.65%)
Predicted Date (Avg) 2026-06-13
Predicted Date Range (~68%) 2026-06-11 - 2026-06-15
Basis Based on 1 historical gains (Avg: 16.54%, Median: 16.54%, StdDev: 0.00%) and duration (Avg: 8.5 days, StdDev: 2.1 days)
Note Ranges assume ~normal distribution & historical patterns repeat. Use with caution.

Slight loss for Nurix Therapeutics Inc.

Nurix Therapeutics Inc (NRIX) stock price showed a minimal loss on Friday after the stock fell $-0.0300 (-0.18%) from the previous session on below-average volume. The stock slightly underperformed the market, lagging slightly behind the NASDAQ's 0.31% rise. Yesterday's trading volume was 2.56M shares, worth about $43.44M. This represents 1.47M shares less than the day before. Volume was below the 10-day average of 4.19M shares.

Nurix Therapeutics Inc signals

There is no conclusive signals given from RSI. The price is above both moving averages, but the short-term average remains below the long-term average; upward momentum is present but not yet fully confirmed. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (16.7%), medium- (16.7%), and long-term (16.7%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.

Nurix Therapeutics Inc Support & Resistance Levels

The stock is approaching the closest resistance level at $17.00. approximately $0.0500 (0.29%) away. Consolidating near resistance. Breaking above this level could signal further upside where next resistance level will be found at $18.5. On a fall back there will be support at $15.6 The dis das resistance s115.6 -

Nurix Therapeutics Inc Evaluation

  • Short score: 0.82
  • Medium score: 2.50
  • Long score: 2.08